Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

The small size of this community and its regular participation in drugs tests would lead many to believe that it should be easier to obtain relatively accurate prevalence data. However, despite these preconceptions it may in fact be more difficult to assess the prevalence of AS use in this community than in other populations. Severe penalties are imposed by the International Olympic Committee (IOC) and many other sporting bodies if the use of AS is detected. The penalties of a positive drugs test may also have serious repercussions for the public image and financial situation of the athletes and their sport. For these reasons it may be difficult to get AS-using athletes to admit to their drug use, and to give honest responses to questions about the drug use within their area of sport. It is also difficult to rely on the  number of positive drugs tests to determine prevalence of AS use. A variety of methods have been used by athletes to avoid detection in drugs tests. The use of masking agents, catheterization of urine, sample substitution and sample manipulation are just a few of the methods previously used (Voy, 1991; Mottram, 1996).

An additional difficulty encountered when relying upon positive drug test results to indicate prevalence rates for AS use is related to the way in which these substances are used. Anabolic steroids may be used during pre-competition training periods, and if the athlete ceases to use these substances in enough time before a competition drug test  detection they may avoid the detection of illicit substances (Goldman and Klatz, 1992). Thus, the positive drug test data do not provide an overall view of the use of AS among the athletic community (Dubin, 1990). It has been  suggested that out-of-competition drug testing may combat this type of behaviour. However, the success of out-of-competition testing in reducing the international spread of AS use in sport depends upon international co-operation. If certain countries are proceeding with out-of-competition testing when others are not, there could be difficulties in maintaining fair competition at international sporting events. Other difficulties in the implementation of such a strategy are related to the diligence with which each country implements this type of testing regime. The financial burdens that may be created by such a scheme could present difficulties for Third-World or developing countries. This problem was highlighted as early as 1990 when the Dubin Report (1990) suggested that perhaps Canada should not compete against countries where out-of-competition testing did not occur. It also suggested that the International Amateur Athletic Federation (IAAF) should provide financial support to countries in which out-of-competition testing may be difficult to conduct because of technical difficulties and financial costs.

A study of the prevalence of doping in sports in Norway from 1977 to 1995 (Bahr and Tjornhom, 1998) showed that an increase in the frequency of doping tests was associated with a decrease in the percentage of positive samples in targeted sports. This study involved a total of 15,208 athletes, most of whom belonged to national federations under  the jurisdiction of the Norwegian Confederation of Sport (NCS), and it is interesting to note that 90% of the tests performed were unannounced.

In the past, AS have been frequently associated with strength-dependent sports such as weightlifting and wrestling. It has been suggested that certain athletes may use AS in the belief that this is the only way in which they can compete with drug-using competitors (Heikkala, 1993; Black and Pape, 1997). It would be logical to assume that this type of  drug use may be selfperpetuating in that participants in sports previously associated with a high prevalence of AS use are more likely to use AS for this reason. However, the use of AS is not exclusive to these types of sports, and reports of  AS use by swimmers, cyclists and sprinters have been frequent (George, 1996a; Verroken, 1996). Some of the potential effects of AS use are clearly more beneficial to certain sports than others. Thus it would be expected that the  prevalence rates for AS use in sports such as figure skating, where high muscle mass, or ‘bulk’, is not a crucial factor for success, might be less than in the more conventional strength sports such as weightlifting (Yen and Jaffe, 1978; Francis, 1990).

The actual prevalence rates of AS use among elite athletes are believed to be high (Dubin, 1990). In a testimony about the use of AS by US athletes between the 1984 and 1988 Olympics, Pat Connolly declared that at least 40% of the women’s team in Seoul had probably used steroids at some time in their preparations for the games. This again  highlights the issue of out-of-competition use of AS.

A prevalence study of powerlifters in the USA (Curry and Wagman, 1999) reviewed the use of AS among 28 members of teams of US powerlifters. Of the 15 members that returned the postal questionnaires, 10 admitted using AS, and five admitted they had evaded the IOC’s doping control procedures while using AS.

Scarpino et al. (1990) carried out research about the prevalence of doping among Italian athletes. Their work involved 1015 Italian athletes and 216 coaches, doctors and managers. Results showed that over 10% of the athletes admitted to frequent use of AS at national- and international-level sport. It is interesting that 62% of the athletes that  acknowledged doping stated that there was pressure from coaches and managers to use doping methods to improve performance. The research also stated that 70% of the athletes felt that access to illegal substances was easy.

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

The use of Anabolic Steroids as performance-enhancing drugs among sportsmen spread throughout the world within two decades. Body-builders on the West Coast of America experimented with steroid preparations throughout the late
1940s and early 1950s (Goldman and Klatz, 1992; Yesalis et al., 1993b). Understandably, as stories of their success spread, competitors in other strength-intensive sports began using the drugs to enhance their performance on the track and field. Over the past 40 years, the use of Anabolic Steroids has taken place in an increasing number of sports, including football, swimming, cycling, wrestling and many more (Wallechinsky, 1996). Steroid use is even well documented among athletes in college and high school (Buckley et al., 1988; Johnson et al., 1989; Schroff, 1992).

Anabolic steroid users from different sports use different doses of Anabolic Steroids. Doses used by endurance athletes tend to be at or below  physiologic replacement levels, whereas athletes in sports where ‘bulk’ is desirable, e.g. weightlifting, use doses far in excess of physiologic levels (Yen and Jaffe, 1978; Francis, 1990; Yesalis, 1993). The close community of many elite-level teams may have influenced the various doses used by different athletes; a swimmer would obviously be less likely to desire the same ‘bulkiness’ as a weightlifter, or wrestler. It is possible that as Anabolic Steroids use spread into the different types of sports, so did advice from more experienced users. Anabolic steroids may be used by athletes to improve  their performance in the precompetition period. The difference between AS as doping agents and other drugs, such as amphetamines or cocaine, is that AS may be used during training sessions to produce improvements, but their use can  be ceased before the competition and therefore the chance of detection in drugs tests may be reduced. Anabolic  steroids are usually used in cycles. An ‘on-cycle’ is the number of weeks for which the AS are used; an on-cycle is  generally followed by a period of abstinence from Anabolic Steroids, or an ‘off-cycle’. The length of time for which the individual uses  Anabolic Steroids tends to be variable, with an average on-cycle lasting from between 8 to 12 weeks and an off-cycle of similar duration (Yesalis, 1993). However, there are reports that some AS users administer AS on a continual basis (Duchaine,  1989; Lenehan et al., 1996). Most of the other doping methods are based entirely on the principle of improving performance on a more short-term basis by drug use immediately before a competiton or event (Goldman and Klatz, 1992).

Tests for Anabolic Steroids were developed by Donike in the 1960s; the early tests used a gas chromatography method to detect the presence of Anabolic Steroids, and Anabolic Steroids metabolites, in urine (Donike and Stratmann, 1974). Athletes that test positive for any  substance may face severe penalties and as the tests have progressively become more sophisticated and sensitive, many involved in elite sport have attempted to apply a variety of methods to avoid detection (Voy, 1991; Goldman and Klatz, 1992). The concomitant use of other drugs, such as masking agents, to avoid detection in drugs tests, e.g. Probnecid, or drugs to ameliorate adverse effects of Anabolic Steroids has become part of the Anabolic Steroids-using culture (Lenehan et al., 1996).

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

Perhaps the first suggestion that testosterone might be useful in aiding sporting performance came from the work of Oskar Zoth and Fritz Pregl in 1886. As an alternative to testicular transplantation, Zoth and Pregl undertook a study using testicular extracts. These two Austrian scientists aimed to determine whether the aqueous extracts could improve muscle strength and, thus, improve athletic performance. They injected themselves with a liquid extract from bull’s testicles and then measured the strength of their middle fingers throughout a series of exercises. Their paper, published in 1896, concluded that the extract had improved the strength and condition of their muscles. Moreover, they went on to suggest that further research be carried out within the athletic community for practical assessment of their initial results. The writer Paul de Kruif reported on the developments in the synthesis and therapeutic  applications of testosterone. During the 1940s he commented on the potential of these substances to improve the athletic performance of baseball teams. However, these reports were essentially indications of the potential  performance-enhancing abilities of testosterone and its derivatives. The first accurate and controlled studies into this aspect of sports doping were produced in the 1950s.

The American scientist Dr John Ziegler produced some of the most influential work into the effects of AS upon sporting performance. Indeed, Ziegler was responsible for the original synthesis of AS (Taylor, 1991; Goldman and Klatz, 1992; Yesalis et al., 1993a; Hoberman and Yesalis, 1995). In 1956 Ziegler attended the World Games, and at this competition
he learnt of the Russian athletes’ use of hormonal treatments for performance enhancement. On his return Ziegler  reported his findings and, funded by the pharmaceutical company Ciba, went on to synthesize the first AS. He named this compound Dianabol.

Since the development of Dianabol an enormous range of AS has become available. Pharmaceutical companies have continued to research methods to dissociate the ‘desirable’ anabolic effects from the androgenic effects, but as yet they have had very limited success. Some of the AS available have lower androgenic components than others, but androgenic effects have not been entirely eliminated from any product (Haupt and Rovere, 1984).

The period of the 1960s and 1970s saw an increase in the number of people using AS, and also an increase in the range of AS commercially available (Taylor, 1991). However, the medical and sporting institutions were still viewing these substances with suspicion. In both America and Britain, research as to whether AS did improve athletic performance was conflicting ( Johnson and O’Shea, 1968; Freed et al., 1975; Hervey et al., 1976; Ryan, 1978). In 1975, the British Association of Sport and Medicine (BASM) announced that AS were not capable of producing an improvement in performance. The policy of the American College of Sports Medicine (ACSM) was published in their 1977 annual report; this report stated that there was no conclusive scientific evidence to suggest that AS improve athletic performance.

In fact, it was only in the 1980s that it became accepted that, under specified circumstances, AS are capable of producing an improvement in sporting performance. The specific circumstances were that:

the athlete must have been undergoing an intensive weightlifting programme before starting the course of Anabolic Steroids;
the athlete must continue this intensive training programme throughout the course of Anabolic Steroids;
the athlete must consume a high protein diet.

It also recommended that changes in the strength of the athlete must be measured by the single repetition-maximal weight technique for the exercises in which the athlete trains (Haupt and Rovere, 1984).

After it had become widely accepted that AS could enhance sporting performance, the medical and sporting  institutions were forced to change their public policies. The sporting institutions continued to maintain an anti-doping stance. They now had to find some way of deterring athletes from using drugs that were scientifically proven to  enhance performance. To compound matters, there was already a significant lack of credibility between the sports medicine and the athletic communities due in no small part to the previous denial of the sport medical community as to the performance-enhancing properties of AS (Haupt and Rovere, 1984). Any research documenting the adverse effects of these drugs was likely to be viewed sceptically by athletes.

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid

There are rumours that German soldiers were administered anabolic steroids during the Second World War, the aim being to increase their aggression and stamina (Yesalis et al., 1993a). These rumours have often been reported (Verroken, 1996) but are, as yet, unproven. Hitler was also believed to have been treated by his physician with injections of testosterone (Taylor, 1991). A more ethical application of anabolic steroid treatment was also
applied at the end of the Second World War, whereby these drugs were used to treat the malnourished victims of the Nazi concentration camps (George, 1996a).

Other early uses were found for testosterone derivatives in the treatment of men and women with abnormal hormone production. The mode of action of these treatments works on almost identical principles to the primitive transplantation of testicular tissue; exogenous testosterone circulates around the body to fulfil the roles of  endogenous testosterone. The first documented case of testosterone being used to treat a patient was by Hamilton (1937). This physician administered a total of 550 mg of testosterone acetate, given via 14 injections with three injections per week, to a 27-year-old male patient who was suffering from sexual underdevelopment (hypogonadism). Hamilton’s experiment proved to be successful, the patient experienced penile erections, deepening of voice,  elevation of mood, and growth of body hair. Hamilton’s work also provided an early indication of the potential  side-effects of testosterone, or testosterone derivatives; the patient was recorded to have developed acne on his back and chest and experienced hot flushes. Testosterone derivatives are still used to treat this disorder today, although the doses used and the drugs themselves have undergone significant development and modification.

Following the work of Hamilton, a series of reports documented the use of testosterone in the treatment of male involutional melancholia (Barahal, 1938; Danzinger and Blank, 1942; Goldman and Markham, 1942; Davidoff and Goodstone, 1942); this syndrome is believed to be caused by the decrease in testosterone level brought about by the aging process. The research had varying levels of success, but primarily served as a precursor for later research into the application of testosterone-derived treatments in the field of mental health.

In the late 1930s and early 1940s, research was also conducted into the use of testosterone derivatives in the  treatment of cardiovascular disorders (Taylor, 1991). Medical and scientific knowledge of today suggests that there is an association between the use and misuse of testosterone and its derivatives and cardiovascular disorders such as  myocardial infarction, hypertension and cardiomyopathy (Greenberg et al., 1974; Pearson et al., 1986; Ferenchick, 1990; Ferenchick et al., 1991; Rockhold, 1993; Melchert and Welder, 1995). The use of testosterone as an  anti-oestrogen treatment for female breast tumours led to a secondary and more controversial use for testosterone. It has been reported that, during this period, testosterone was administered to homosexual men in the belief that  homosexuality was caused by abnormally high levels of female hormones in men (Lenehan et al., 1996).

Anabolex Dianabol Dbol D bol Methandrostenolone Steroid